Dr. Mukhtar Hassan, MD

Dr. Hassan practices at UPMC Horizon - Greenville in Greenville, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Hassan's NPI, 1609929066, was assigned on January 19, 2007. Dr. Hassan holds District of Columbia license MD32758.

Dr. Hassan's primary practice is UPMC Horizon - Greenville, at 110 North Main Street, Greenville, PA 16125 in Mercer County. The practice phone is (724) 588-2100.

Dr. Hassan's primary practice is UPMC Horizon - Greenville in Greenville, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Hassan is also affiliated with UPMC Presbyterian. The medical group on file is UPMC Hillman Cancer Center. Dmand AI also links Dr. Hassan to 3 more hospitals and 1 breast imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hassan practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Hassan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Hassan is licensed in District of Columbia.

CMS data shows 869 Medicare services from Dr. Hassan across 7 procedure codes in 2024, for 274 Medicare patients. Medicare paid $52,355 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 274 Medicare patients who saw Dr. Hassan in 2024. The largest group is 65 to 74, with 106 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hassan's median patient age at 76, with 60% women.

In 2024, Dr. Hassan wrote 465 Medicare Part D claims for 145 patients. 87% of them were for generic drugs. CMS names the drug for 345 of them, across 13 drugs with 11 or more claims each, at $44,807 in total drug cost. In 2023, CMS named 289 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 65 out of 100 for Dr. Hassan for performance year 2024, reported as part of a group. Dr. Hassan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 202 general payments to Dr. Hassan from 30 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 93% of the total. Bristol-Myers Squibb Company paid the most, $475.